Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Boehringer Ingelheim
Queensland Health
Johnson and Johnson
Colorcon
Argus Health
Medtronic
Express Scripts
Deloitte
Mallinckrodt

Generated: February 19, 2018

DrugPatentWatch Database Preview

POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

When do Potassium Chloride 40meq In Dextrose 5% In Plastic Container patents expire, and what generic alternatives are available?

Potassium Chloride 40meq In Dextrose 5% In Plastic Container is a drug marketed by Baxter Hlthcare and Icu Medical Inc and is included in nine NDAs.

The generic ingredient in POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER is dextrose; potassium chloride. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the dextrose; potassium chloride profile page.
Summary for POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER
Drug patent expirations by year for POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER
Pharmacology for POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER

US Patents and Regulatory Information for POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate INJECTABLE;INJECTION 019367-008 Apr 5, 1985 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Baxter Hlthcare POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER dextrose; potassium chloride; sodium chloride INJECTABLE;INJECTION 019308-007 Apr 5, 1985 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Icu Medical Inc POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER dextrose; potassium chloride; sodium chloride INJECTABLE;INJECTION 018876-004 Mar 28, 1988 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Icu Medical Inc POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER dextrose; potassium chloride; sodium chloride INJECTABLE;INJECTION 019691-009 Mar 24, 1988 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Icu Medical Inc POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate INJECTABLE;INJECTION 019685-004 Oct 17, 1988 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Icu Medical Inc POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER dextrose; potassium chloride; sodium chloride INJECTABLE;INJECTION 018365-004 Jul 5, 1983 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Icu Medical Inc POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER dextrose; potassium chloride; sodium chloride INJECTABLE;INJECTION 018362-003 Approved Prior to Jan 1, 1982 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Baxter Hlthcare POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER dextrose; potassium chloride; sodium chloride INJECTABLE;INJECTION 018008-009 Apr 28, 1982 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Icu Medical Inc POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% IN PLASTIC CONTAINER dextrose; potassium chloride INJECTABLE;INJECTION 018371-002 Approved Prior to Jan 1, 1982 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Boehringer Ingelheim
AstraZeneca
Cipla
UBS
Federal Trade Commission
Fish and Richardson
Johnson and Johnson
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot